HIV and AIDS Trial, Recruiting NCT06560840 Sponsor: Fudan University Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT06560840
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with HIV, according to China's official HIV/AIDS diagnosis guidelines
  • People aged 40 years or older
  • People who are at risk of heart or blood vessel disease, either by having any two of the following: abnormal cholesterol or blood fat levels, diabetes or raised blood sugar, smoking, high blood pressure or raised blood pressure readings, metabolic syndrome, or being overweight or obese — or by having a cardiovascular risk score above 5% (confirm with trial site for how this score is calculated)
  • People whose doctors expect them to survive for more than one year
  • People who do not plan to leave the study location within the next 3 months
  • People who are willing to take part and have signed a consent form agreeing to join the study

Who may not be able to join:

  • People who have previously had a heart attack, stroke, or other heart or blood vessel disease
  • People who have HIV-related cognitive or memory problems, Alzheimer's disease, dementia, or serious HIV-related infections
  • People currently living with cancer, digestive or gastrointestinal conditions, or who have an aversion to eating
  • People who have an allergy to nuts or fish
  • People who currently take more than 1,000 mg of supplemental calcium per day, or who take omega-3 supplements
  • People who plan to become pregnant within the next 6 months
  • People who are currently taking part in another research study related to HIV or to dietary changes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hongzhou Lu, Dr, Shenzhen Third People's Hospital

Phone: 13320178333

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 August 2024
Est. completion
20 May 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

10-year ASCVD risk assessed by the Pooled Cohort Equations; Gut microbiota diversity and composition

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov